Oppenheimer & Co. Inc. Lowers Stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Oppenheimer & Co. Inc. cut its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 36,819 shares of the medical instruments supplier’s stock after selling 250 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in DENTSPLY SIRONA were worth $1,826,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in XRAY. BlackRock Inc. lifted its stake in DENTSPLY SIRONA by 1.8% in the fourth quarter. BlackRock Inc. now owns 14,334,332 shares of the medical instruments supplier’s stock valued at $533,380,000 after acquiring an additional 257,243 shares during the last quarter. Mackenzie Financial Corp lifted its stake in shares of DENTSPLY SIRONA by 17.3% in the fourth quarter. Mackenzie Financial Corp now owns 10,090,056 shares of the medical instruments supplier’s stock worth $375,451,000 after buying an additional 1,490,134 shares during the last quarter. Morgan Stanley lifted its stake in shares of DENTSPLY SIRONA by 1,233.9% in the third quarter. Morgan Stanley now owns 5,242,702 shares of the medical instruments supplier’s stock worth $197,860,000 after buying an additional 4,849,652 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of DENTSPLY SIRONA by 6.6% in the fourth quarter. Geode Capital Management LLC now owns 2,997,698 shares of the medical instruments supplier’s stock worth $111,355,000 after buying an additional 185,780 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of DENTSPLY SIRONA by 3.3% in the fourth quarter. Northern Trust Corp now owns 2,581,330 shares of the medical instruments supplier’s stock worth $96,050,000 after buying an additional 82,902 shares during the last quarter. Institutional investors own 95.83% of the company’s stock.

Several equities analysts recently commented on the stock. Guggenheim started coverage on shares of DENTSPLY SIRONA in a report on Wednesday, April 17th. They issued a “neutral” rating and a $54.00 price target on the stock. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Monday, May 6th. HC Wainwright reissued a “neutral” rating and issued a $55.00 price target (up previously from $49.00) on shares of DENTSPLY SIRONA in a report on Monday, May 6th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a report on Monday, May 6th. Finally, William Blair raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $56.71 target price on the stock in a report on Monday, March 18th. Eight research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Buy” and an average price target of $53.55.

In related news, SVP Maureen J. Macinnis sold 54,402 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $55.00, for a total transaction of $2,992,110.00. Following the completion of the sale, the senior vice president now directly owns 50,962 shares of the company’s stock, valued at approximately $2,802,910. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Daniel P. Key purchased 3,697 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The shares were acquired at an average cost of $54.68 per share, with a total value of $202,151.96. Following the completion of the purchase, the senior vice president now directly owns 9,024 shares in the company, valued at $493,432.32. The disclosure for this purchase can be found here. Insiders sold a total of 123,922 shares of company stock worth $6,790,905 over the last quarter. 0.62% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA stock traded down $0.30 during trading hours on Wednesday, reaching $54.62. 1,749,033 shares of the company’s stock traded hands, compared to its average volume of 1,851,965. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $55.88. The company has a market cap of $12.78 billion, a PE ratio of 27.17, a PEG ratio of 2.03 and a beta of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The company had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. During the same period in the prior year, the company posted $0.45 EPS. The company’s revenue was down 1.0% compared to the same quarter last year. Research analysts forecast that DENTSPLY SIRONA Inc will post 2.34 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.64%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 17.41%.

COPYRIGHT VIOLATION WARNING: “Oppenheimer & Co. Inc. Lowers Stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY)” was originally reported by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://sundanceherald.com/2019/05/22/oppenheimer-co-inc-sells-250-shares-of-dentsply-sirona-inc-xray.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: What is Put Option Volume?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply